In 2023, CSPC Pharmaceutical Group conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, CSPC Pharmaceutical Group generated a total of 38,769 metric tonnes of waste.
Of this amount, 33.59% of CSPC Pharmaceutical Group's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 66.41% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2020, CSPC Pharmaceutical Group's total waste generation decreased by 19.71%, with an additional 19.31% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.
Over the same period, the share of hazardous waste decreased by 7.03%, yet rose by 13.67% in 2023, potentially signaling operational variability, temporary setbacks, or less effective hazardous waste mitigation in the short term.
Overall, CSPC Pharmaceutical Group's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.